# Langaware

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/langaware

- Industry: Healthcare IT
- Headquarters: US
- Website: https://homepage.langaware.net/
- Total disclosed funding: $2M
- Latest round: Seed (Oct 4, 2023)
- Investors on record: 3

## About

Based in California, US, and founded in 2019 by CEO Dr. Vassiliki Rentoumi, Langaware, Inc., a.k.a. Langaware Health operates a healthcare technology company that leverages artificial intelligence technology to detect mental health disorders at an early stage to support personalized care. In October 2023, Langaware, Inc. raised USD 2 million in seed funding led by Eleven Ventures, with participation from Metavallon VC.

The company has developed a machine learning workflow based on multimodal biomarkers to facilitate the early detection of neurodegenerative and mental health diseases across different languages. LANGaware employs artificial intelligence to predict and monitor cognitive and mental health conditions like mild cognitive decline, Alzheimer’s disease, and depression. The firm’s machine learning workflow analyzes language, speech, and voice to help health systems, providers, and pharma firms facilitate early detection and tailored support.

The company plans to use its proceeds from October 2023 funding to expand its business development and further develop its market.

## Funding rounds

- Seed, Oct 4, 2023, $2M — Eleven Ventures, Metavallon VC, Cleverage VC

## Investors

- Eleven Ventures — Seed
- Metavallon VC (https://capitalatlas.ai/funds/metavallon-vc) — Seed
- Cleverage VC (https://capitalatlas.ai/funds/cleverage-vc) — Seed